# Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: COVPN 3004 Boost

> **NIH NIH UM1** · UNIVERSITY OF MARYLAND BALTIMORE · 2022 · $1,382,804

## Abstract

Novavax CoVPN 3004 Adult and Pediatric Booster Administration
Project Summary/Abstract:
Novavax Adult and Pediatric booster
To date, 485 adult and 29 pediatric participants have received the initial series of vaccinations, had associated
follow-up visits, and participated in a blinded cross-over. We estimate 380 adult and 29 pediatric participants
will be invited to receive booster dose of vaccine and participate in associated follow-up visits. Blood and other
protocol-required specimens collected at theses visits will be processed, stored, and shipped per protocol.
Data will be entered, and data queries will be resolved in a timely manner.
Surveillance for illness visits will continue and with the advent of new variants, it is expected illness visits will
increase following major holidays with a gradual reduction to follow.

## Key facts

- **NIH application ID:** 10639869
- **Project number:** 3UM1AI148689-03S8
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** Karen L. Kotloff
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,382,804
- **Award type:** 3
- **Project period:** 2022-08-22 → 2023-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10639869

## Citation

> US National Institutes of Health, RePORTER application 10639869, Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: COVPN 3004 Boost (3UM1AI148689-03S8). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10639869. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*